Pharmacologic profile of the selective mitochondrial-KATP opener BMS-191095 for treatment of acute myocardial ischemia

Cardiovascular Drug Reviews

Volumn 20, Issue 2, 2002, Pages 121-136

  Grover, Gary J ^a   Atwal, Karnail S ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

BMS 191095; KATP channels; Myocardial ischemia

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; ADENOSINE TRIPHOSPHATE; APRIKALIM; BMS 191095; CROMAKALIM; LACTATE DEHYDROGENASE; N (4 CHLOROPHENYL) N' CYANO N'' (6 CYANO 3,4 DIHYDRO 3 HYDROXY 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)GUANIDINE; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG HALF LIFE; DRUG POTENCY; ELECTROPHYSIOLOGY; ENZYME RELEASE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; HEART MUSCLE REPERFUSION; HEART PROARRHYTHMIA; HEART PROTECTION; HEMODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; REVIEW; SARCOLEMMA; STRUCTURE ACTIVITY RELATION; VASODILATATION;

EID: 0036392152     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2002.tb00187.x     Document Type: Review

References (30)

1. Armstrong S, Liu G, Downey J, Ganote, C. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: Effects of glyburide and pinacidil. J Mol Cell Cardiol 1995;27:1765-1774.
2. Atwal K, Grover G, Ahmed S, et al. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J Med Chem 1993;36:3971-3974.
3. Belin N, Hodge T, Picaut P, et al. The myocardial lesions produced by the potassium channel opener aprikalim in monkeys and rats are prevented by blockade of cardiac alpha-adrenoceptors. Fund Appl Toxicol 1996;31:259-267.
4. ATP channels. Diabetes 1996;45:1439-1445.
5. ATP channels in guinea pig ventricular cells. Am J Physiol 1995;269:H1625-1633.
6. - channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-581.
7. Edwards G, Weston A. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33:597-637.
8. ATP channel as a receptor for potassium channel openers. J Biol Chem 1996;271:8796-8799.
9. Garlid KD, Paucek P, Yarov-Yarovoy B, et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive potassium channels: Possible mechanism of cardioprotection. Circ Res 1997;81:1072-1082.
10. Grover GJ, Garlid KD. ATP-sensitive potassium channels: A review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000;32:677-695.
11. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 1995;26:145-152.
12. ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J Cardiovasc Pharmacol 1995;265:695-706.
13. ATP opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther 2001;297:1184-1192.
14. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104.
15. Grover G, Newburger J, Sleph P, et al. Cardioprotective effects of the potassium channel opener cromakalim: Stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 1991;257:156-162.
16. ATP opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther 2001;297:1184-1192.
17. ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270:1166-1170.
18. + channels. Neuron 1996;16:1011-1017.
19. + channel in the mitochondrial inner membrane. Nature 1991;352:244-247.
20. Kim D, Clapham D. Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science 1989;244:1174-1176.
21. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 1990;259:H820-H826.
22. + channel by long chain acyl-CoA. J Biol Chem 1996;271:10623-10626.
23. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998;97:2463-2469.
24. McCullough J, Normandin D, Conder M, Sleph P, Dzwonczyk S, Grover G. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 1991;69:949-958.
25. + channels involves high-energy phosphate preservation. Am J Physiol 1993;265:H 1809-1818.
26. ATP channels and nitric oxide in conscious dogs. Circulation 1997;95:1568-1576.
27. + channel from rat liver and beef heart mitochondria. J Biol Chem 1992;267:26062-26069.
28. ATP) openers. 5. Identification of 4-(N-Aryl)-substituted benzopyran derivatives with high selectivity. J Med Chem 1997;40:24-34.
29. Wilde AAM, Janse MJ. Electrophysiological effects of ATP senstivie potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 1994;28:16-24.
30. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-1775.